Prescription drug · ANDA
Carglumic Acid NDC 71863-114
Carglumic acid 200 mg/1 · Tablet, For suspension · Oral · Eton Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71863-114-60 | 7186301146071863011460 | 1 BOTTLE in 1 CARTON (71863-114-60) / 60 TABLET, FOR SUSPENSION in 1 BOTTLEMarketed from Dec 20, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carglumic Acid
- Generic name (nonproprietary)
- carglumic acid
- Active ingredients
- Carglumic acid — 200 mg/1
- Dosage form
- Tablet, For suspension
- Route
- Oral
- Labeler
- Eton Pharmaceuticals, Inc.NDC labeler code 71863
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213729
- Marketing start
- Listing expires
- Other FDA classes
- Carbamoyl Phosphate Synthetase 1 Activators (Mechanism)
- Identifiers
- Product ID 71863-114_ce6d0fd4-bbe0-4a22-bfb5-33326b63a67fSPL ID ce6d0fd4-bbe0-4a22-bfb5-33326b63a67fSPL set ID 591f95ca-3d99-4fb6-a402-e5a383a746d0RxCUI 905390UNII 5L0HB4V1EW
- Pharmacologic class
- Carbamoyl Phosphate Synthetase 1 Activator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471863011460followed by a unit qualifier and the quantityPackage 71863-0114-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Carglumic acid tablets for oral suspension is a carbamoyl phosphate synthetase 1 (CPS 1) activator indicated in pediatric and adult patients as: Adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. (1.1) Maintenance therapy for the treatment of chronic hyperammonemia due to NAGS deficiency. (1.1) 1.1 Acute and Chronic Hyperammonemia due to N-acetylglutamate Synthase (NAGS) Deficiency Carglumic acid tablets for oral suspension are indicated in adult and pediatric patients as: Adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to NAGS deficiency. Maintenance therapy for the treatm…
Excerpt only. Read the full label for complete information.
About NDC 71863-114
- What is NDC 71863-114?
- 71863-114 is the product NDC for Carglumic Acid, Carglumic acid 200 mg/1 tablet, for suspension, listed with the FDA by Eton Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Carglumic Acid.
- What is the active ingredient?
- Carglumic acid.
- Who is the labeler?
- Eton Pharmaceuticals, Inc., NDC labeler code 71863. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Carglumic Acid?
- 2 other product NDCs are listed under this name. See all Carglumic Acid NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Carglumic Acid products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Carglumic acid | Carglumic acid 200 mg/1 | Tablet, For suspensionOral | Burel Pharmaceuticals, LLC | 35573-459 | 35573-0459-60 |
| Carglumic acid | Carglumic acid 200 mg/1 | Tablet, For suspensionOral | Navinta LLC | 68475-006 | 68475-0006-0168475-0006-02 |